Serum carcinoembryonic antigen level in surgically resected clinical stage i patients with non-small cell lung cancer
- 1 July 2002
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 74 (1) , 174-179
- https://doi.org/10.1016/s0003-4975(02)03662-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical Predictors of N2 Disease in Non-small Cell Lung CancerChest, 2000
- Induction chemotherapy before surgery for early-stage lung cancer: A novel approachThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Prognostic factors in clinical stage I non–small cell lung cancerThe Annals of Thoracic Surgery, 1999
- Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Analysis of the early postoperative serum carcinoembryonic antigen time-course as a prognostic tool for bronchogenic carcinomaCancer, 1997
- Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancerBritish Journal of Cancer, 1996
- Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancerThe Annals of Thoracic Surgery, 1994
- Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapyCancer, 1986
- Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinomaCancer, 1978
- Carcinoembryonic antigen in 228 patients with carcinoma of the lungCancer, 1975